The Miami Heat are more open to the idea of Chris Bosh playing on blood thinners next season, reports Barry Jackson of the Miami Herald, citing a source.
Bosh had pitched the idea of playing while on blood thinners last season, but the possibility was swiftly rejected by the Heat.
There is growing optimism about Chris Bosh being cleared by the Heat to resume his career while remaining on blood thinners, according to a union source.
Bosh pitched the Heat on playing late last season, while taking a new form of blood thinner that would be out of his system in eight hours or so.The Heat resisted that approach at that time but is now more open than it had been to Bosh playing while on blood thinners, according to the source.
Bosh wouldn’t be the first athlete to do that: Former Florida Panthers player Tomas Fleischmann takes anticoagulant injections after games that are out of his system by game time.
Whether Bosh would be able to play in every game, such as the second set of back-to-backs, remains to be seen.
Retaining Bosh would be a major plus for Heat fans, who’ve been deprived of nearly every member from the team’s 2013 championship roster.
Should Bosh be cleared to play, the Heat would have one of the most formidable frontcourt tandems in the league with a Bosh-Whiteside combo.
Bosh averaged 19.1 points and 7.4 rebounds in just 53 games with the Heat last season.
The past two seasons for Bosh have been cut short due to the recurring blood clot issue, but if he does return and stays healthy, the Heat would likely contend for a Playoff spot.
